DBV Technologies (DBVT) Shareholder's Equity Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10% |
| Dec 31, 2025 | -4.61% |
| Sep 30, 2025 | -37.07% |
| Jun 30, 2025 | -29.34% |
| Mar 31, 2025 | -67.18% |
| Dec 31, 2024 | -34.89% |
| Sep 30, 2024 | -22.68% |
| Jun 30, 2024 | -17.92% |
| Mar 31, 2024 | -12.93% |
| Dec 31, 2023 | -11.97% |
| Sep 30, 2023 | -14.83% |
| Jun 30, 2023 | -13.27% |
| Mar 31, 2023 | -15.77% |
| Dec 31, 2022 | 0.79% |
| Sep 30, 2022 | 30.45% |
| Jun 30, 2022 | 23.20% |
| Dec 31, 2021 | -10.49% |
| Jun 30, 2021 | -16.38% |
| Dec 31, 2020 | 10.34% |
| Jun 30, 2020 | 6.10% |
| Dec 31, 2019 | -10.20% |
| Jun 30, 2019 | -26.43% |
| Dec 31, 2018 | -26.81% |
| Jun 30, 2018 | 27.95% |
| Dec 31, 2017 | 1.97% |